| (KRW) | Dec 2019 | Y/Y change |
|---|---|---|
| Revenue | 1.02B | -29.95% |
| Operating expense | — | — |
| Net income | -6.30B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 293780.KQ returned -21.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -33.9% |
| 1 year | -21.5% |
| 5 years | -89.3% |
| All-time high | ₩58,000 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₩1,000 in 293780.KQ would be worth today ›No. AptaBio Therapeutics Inc. has not paid a dividend in the past 12 months.
AptaBio Therapeutics Inc. is part of the Healthcare sector.
AptaBio Therapeutics Inc. has a market cap of 173.62B KRW, based on the latest quote.
